Zobrazeno 1 - 10
of 133
pro vyhledávání: '"major adverse cardiac events (mace)"'
Autor:
Khalaf Kridin, Katja Bieber, Artem Vorobyev, Eva Lotta Moderegger, Henning Olbrich, Marlene A. Ludwig, Bernard Gershater, Gema Hernandez, Henner Zirpel, Diamant Thaci, Ralf J. Ludwig
Publikováno v:
EBioMedicine, Vol 111, Iss , Pp 105485- (2025)
Summary: Background: Cardiovascular comorbidity increases morbidity and mortality in psoriasis. Systemic treatments, particularly biologics, are effective in alleviating skin and joint inflammation. Conversely, the impact of systemic therapy on cardi
Externí odkaz:
https://doaj.org/article/6e7607f3fcca479cbb74eef645ab7de2
Publikováno v:
Biomolecules & Biomedicine (2024)
Advancements in artificial intelligence (AI) offer promising tools for improving diagnostic accuracy and patient outcomes in cardiovascular medicine. This study explores the potential of AI-assisted measurements in enhancing the prediction of major a
Externí odkaz:
https://doaj.org/article/10e4cf9bcce740a689f1dc2780abb286
Autor:
Elisabetta Nardella, Federico Biscetti, Maria Margherita Rando, Andrea Leonardo Cecchini, Maria Anna Nicolazzi, Enrica Rossini, Flavia Angelini, Roberto Iezzi, Luis H. Eraso, Paul J. Dimuzio, Dario Pitocco, Massimo Massetti, Antonio Gasbarrini, Andrea Flex
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-12 (2023)
Abstract Background Lower-extremity endovascular revascularization (LER) is often required for diabetic patients with chronic limb threatening ischemia (CLTI). During the post-revascularization period patients may unpredictably experience major adver
Externí odkaz:
https://doaj.org/article/7feac66722f4441588b23fa62d5b6814
Autor:
Hiromi W.L. Koh, Anna P. Pilbrow, Sock Hwee Tan, Qing Zhao, Peter I. Benke, Bo Burla, Federico Torta, John W. Pickering, Richard Troughton, Christopher Pemberton, Wern-Miin Soo, Lieng Hsi Ling, Robert N. Doughty, Hyungwon Choi, Markus R. Wenk, A. Mark Richards, Mark Y. Chan
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
BackgroundPatients suffering from acute myocardial infarction (AMI) are at risk of secondary outcomes including major adverse cardiovascular events (MACE) and heart failure (HF). Comprehensive molecular phenotyping and cardiac imaging during the post
Externí odkaz:
https://doaj.org/article/b8f723c535b84f859a7ca0e4a88409b3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dániel Tornyos, Maximilian Meuer, Réka Lukács, Oumaima El Alaoui El Abdallaoui, Péter Kupó, Réka Faludi, András Komócsi
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundGliflozins altering the sodium-glucose transport protein 2 (SGLT2) in the nephron, represent alone or in combination a promising treatment option for patients with type II diabetes mellitus. In addition to glucose control, these drugs provi
Externí odkaz:
https://doaj.org/article/e6f4156b73dd453b9011cfb2d7c85d14
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Biomedicines, Vol 10, Iss 12, p 3159 (2022)
(1) Background: Practice guidelines define drug-eluting stents (DES) as the standard of care in coronary percutaneous coronary intervention (PCI), including in acute coronary syndrome (ACS). This is based on comparisons with bare-metal stents (BMS).
Externí odkaz:
https://doaj.org/article/ccb3b72a3b144badb4fdc18ccbac5e95
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 14, Iss 1, Pp 1-6 (2019)
Abstract Objective This study aims to discuss the efficacy and safety of the application of thrombus aspiration catheters during emergency PCI operations for acute ST-elevation myocardial infarction (STEMI) patients with high thrombus load. Methods A
Externí odkaz:
https://doaj.org/article/7415e89fbc7c4fb3b301a86b249cca94
Publikováno v:
Platelets, Vol 29, Iss 6, Pp 589-595 (2018)
Numerous number of evidences show that high on-treatment platelet reactivity is a well-known risk factor for adverse events in patients after percutaneous coronary intervention (PCI). Controversial situations still exist regarding the effectiveness o
Externí odkaz:
https://doaj.org/article/2d3a162b6c704466b44d81f2bce6d43a